Stéphanie Harel

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

Sylvain Thépot, Raphaël Itzykson, Valérie Seegers et al. · Blood · 2010 · 156 citations

Medicine, Hematology, Oncology +17

Clinico‐biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases

Stéphanie Harel, M. Mohr, Isabelle Jahn et al. · British Journal of Haematology · 2014 · 130 citations · Full text

Life Sciences, Hematology, Internal Medicine +6

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay, Pedro Castro, Adel Maamar et al. · The Lancet Haematology · 2021 · 99 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma

Fanny Baran‐Marszak, M. Boukhiar, Stéphanie Harel et al. · Haematologica · 2010 · 66 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study

Aurélie Jourdes, Elise Cellerin, Cyrille Touzeau et al. · Clinical Microbiology and Infection · 2024 · 60 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16